Pfizer said sales of Eliquis, hospital products rose in Q1 on COVID-19 demand [MarketWatch]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: MarketWatch
Shares of Pfizer Inc. gained 2.0% in premarket trading on Tuesday after the drugmaker beat expectations for the first quarter. The company had net earnings of $3.4 billion, or 60 cents a share, in the quarter, down from $3.9 billion, or 61 cents per share, in the first quarter of last year. Adjusted per-share earnings came to 80 cents, compared with the FactSet consensus of 73 cents. Pfizer reported $12.0 billion in revenue in the first months of the year, down 8% from the $13.1 billion it reported in the same quarter a year ago. The FactSet consensus was for $11.8 billion. The company said it had a $150 million lift in the quarter that can be attributed to an 11% increase in global sales of its hospital products (some of which are used to intubate and support patients on mechanical ventilators) and a 29% jump in sales of its blood-thinner Eliquis, which was driven by COVID-19-related wholesaler purchases. It also restarted some clinical trials and launched new studies in late April a
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer Obesity Nod In China And Cancer Wins Reframe Long Term Growth [Yahoo! Finance]Yahoo! Finance
- Moderna pays up to $2.25bn to settle drug delivery tech patent lawsuit [Yahoo! Finance]Yahoo! Finance
- Pfizer Bladder Cancer Trial Results Deepen Oncology Growth And Risk Debate [Yahoo! Finance]Yahoo! Finance
- A Look At Pfizer (PFE) Valuation As Long Term Returns And DCF Views Diverge [Yahoo! Finance]Yahoo! Finance
- Pfizer: Obesity Hype And Vaccine Policy Shocks [Seeking Alpha]Seeking Alpha
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- PFE's page on the SEC website